Lazard Asset Management
PGNX

Lazard Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Lazard Asset Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,440
Closed -$70K – 1842
2020
Q1 		$70K Buy
+18,440
New +$70K ﹤0.01% 1082